(Date:11/24/2009)...ZEN,Italy,November24/PRNewswire/--HealthRoboticsto...rewithagroupofselected,investors.Thisrecentlyforme...hRoboticsCanada,Inc.andwillmarket,install,andsuppo...includesthe,revolutionaryproductofferingsi.v.STATI...daInc.willalsoprovideassistanceonan"asneeded,basis...
(Date:11/24/2009)...ATTLE,Nov.24/PRNewswire-FirstCall/--CellTherapeuti...ntatthe21stAnnualPiperJaffrayHealthCareConference....rkPalaceHotel. ,, CTIwillpresentonTuesday,Decem...eaudiowebcastofCTI,spresentationwillbeavailableat ...forreplayafterwards. , ,PiperJaffrayHealthCareCon...
(Date:11/23/2009)...computing promises ultra-fast communication, compu... information. But trying to use quantum states as ...usiness. Now two physicists have shown, mathematic...antum communication, while keeping the information...ue of Physical Review Letters and highlighted wi...
(Date:11/23/2009)...SSISSAUGA,ON,Nov.23/PRNewswire-FirstCall/-YMBioSci...uctdevelopmentcompanythatidentifiesandadvancesadiv...riousstagesofdevelopment,todayreportedthatCytopia(...luatingCYT387,apotent,orally-administeredJAK1/JAK2...chester,Minnesota.AproposaltomergeCytopiaintoYMhas...
Breaking Biology Technology:Health Robotics Continues its Global Expansion With December 09 ASHP's Launch of Joint Venture in Canada 2YM BIOSCIENCES REPORTS FIRST PATIENT IN PHASE I/II TRIAL OF JAK1/JAK2 INHIBITOR, CYT387 ENROLLED BY CYTOPIA 2YM BIOSCIENCES REPORTS FIRST PATIENT IN PHASE I/II TRIAL OF JAK1/JAK2 INHIBITOR, CYT387 ENROLLED BY CYTOPIA 3YM BIOSCIENCES REPORTS FIRST PATIENT IN PHASE I/II TRIAL OF JAK1/JAK2 INHIBITOR, CYT387 ENROLLED BY CYTOPIA 4...truments, Inc., of,Norwood, Massachusetts, announc...f Mart Microbiology B.V. of The Netherlands. The t...Microbiology manufactures and markets the Anoxomat...tom environments for anaerobic,bacteria cultivatio...heres.,Typical applications include the diagnosis ...
...k Inc.,announced today that it has signed an exclu...Prandin(R) (repaglinide). Under the terms of the,a...) and, upon approval by,the US Food and Drug Admin... for a repaglinide/metformin fixed dose combinatio... a right of first refusal to obtain,marketing righ...
...Newswire-FirstCall/ -- Pharmaxis,(ASX: PXS, Nasdaq...n from,its Share Purchase Plan which closed on 9 N...en the opportunity to purchase up to $5,000 worth ...ional investors in the,recent placement. A total ...er which the,company will issue approximately 3 mi...
Other Biology Technology:Advanced Instruments Acquires Mart Microbiology B.V. 2Novo Nordisk Inc. Announces Exclusive Agreement With Sciele Pharma, Inc. to Market Prandin(R) 2Novo Nordisk Inc. Announces Exclusive Agreement With Sciele Pharma, Inc. to Market Prandin(R) 3Pharmaxis Closes Share Purchase Plan 2...mum Essential Medium (Eagle) with 2 mM L-glutamine...er to keep the antigens in their native forms, cel...arrayed on a 12-well (5 mm) adhesive coated slide,...nhance cellular attachment and to minimize backgro...
BD Falcon cultivation flask from BD Biosciences - Discovery Labware
...ced by a patented microwave process which makes a ...ven cell attachment, increased cell growth and yie...uunder difficult conditions, including reduced ser...de a more ecominic alternative to expensive and un...
...are designed for quick and easy protein purificati...two 0.25mm holes laser cut at the conical ends of ...cubation of the gel matrix with buffer, during whi... buffer. Following a centrifugation step, the puri...
Biology Products: